Persistence of tumor-infiltrating CD8 T cells is tumor-dependent but antigen-independent

Cellular and Molecular Immunology

Volumn 8, Issue 5, 2011, Pages 415-423

  Olurinde, Mobolaji O ^a,b,c   Shen, Ching Hung ^b   Drake, Adam ^b   Bai, Ailin ^b   Chen, Jianzhu ^b  

^a HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c Massachusetts Institute of Technology Cambridge   (United States)

Author keywords

antigen; cytokines; tolerance; tumor associated factors; tumor infiltrating lymphocytes

Indexed keywords

INTERLEUKIN 15; INTERLEUKIN 7; TUMOR ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER TISSUE; CD8+ T LYMPHOCYTE; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; IMMUNOLOGICAL TOLERANCE; INFLUENZA; LYMPHOCYTE DEPLETION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PROSTATE TUMOR; SPLEEN; TUMOR ASSOCIATED LEUKOCYTE;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, NEOPLASM; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; EPITOPES, T-LYMPHOCYTE; FLOW CYTOMETRY; HUMANS; IMMUNE TOLERANCE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INTERLEUKIN-15; INTERLEUKIN-7; LYMPHOCYTE ACTIVATION; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PROSTATE; PROSTATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; SPLEEN; TRANSDUCTION, GENETIC;

MUS;

EID: 80052439704     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2011.18     Document Type: Article

References (44)

1. Husby G, Hoagland PM, Strickland RG, Williams RC Jr. Tissue T and B cell infiltration of primary and metastatic cancer. J Clin Invest 1976; 57: 1471-1482
2. von Hanwehr RI, Hofman FM, Taylor CR, Apuzzo ML. Mononuclear lymphoid populations infiltrating the microenvironment of primary CNS tumors. Characterization of cell subsets with monoclonal antibodies. J Neurosurg 1984; 60: 1138-1147 (Pubitemid 14108232)
3. Miescher S, Whiteside TL, Carrel S, von Fliedner V. Functional properties of tumorinfiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes. J Immunol 1986; 136: 1899-1907 (Pubitemid 16119609)
4. Whitford P, Mallon EA, George WD, Campbell AM. Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer. Br J Cancer 1990; 62: 971-975
5. Ademmer K, Ebert M, Muller-Ostermeyer F, Friess H, Buchler MW, Schubert W et al. Effector T lymphocyte subsets in human pancreatic cancer: detection of CD81CD181 cells and CD81CD1031 cells by multi-epitope imaging. Clin Exp Immunol 1998; 112: 21-26 (Pubitemid 28157094)
6. Boon T, Coulie PG, van den Eynde BJ, van der Bruggen P. Human T cell responses against melanoma. Annu Rev Immunol 2006; 24: 175-208
7. Zippelius A, Batard P, Rubio-Godoy V, Bioley G, Lienard D, Lejeune F et al. Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance. Cancer Res 2004; 64: 2865-2873 (Pubitemid 38500627)
8. +T cells in a patient with malignant melanoma ascites. Cancer Immunol Immunother 2006; 55: 1185-1197 (Pubitemid 43992045)
9. Bronte V, Kasic T, Gri G, Gallana K, Borsellino G, Marigo I et al. Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers. J Exp Med 2005; 201: 1257-1268 (Pubitemid 40629069)
10. Greenberg NM, DeMayo F, Finegold MJ, Medina D, Tilley WD, Aspinall JO et al. Prostate cancer in a transgenic mouse. Proc Natl Acad Sci USA 1995; 92: 3439-3443
11. Anderson MJ, Shafer-Weaver K, Greenberg NM, Hurwitz A-A. Tolerization of tumorspecific T cells despite efficient initial priming in a primary murine model of prostate cancer. J Immunol 2007; 178: 1268-1276 (Pubitemid 46154596)
12. +T cells in prostate tumors of TRAMP mice. Proc Natl Acad Sci USA 2008; 105: 13003-13008
13. Shen CH, Ge Q, Talay O, Eisen HN, Garcia-Sastre A, Chen J. Loss of IL-7R and IL-15R expression is associated with disappearance of memory T cells in respiratory tract following influenza infection. J Immunol 2008; 180: 171-178
14. Higham EM, Shen CH, Wittrup KD, Chen J. Cutting edge: delay and reversal of T cell tolerance by intratumoral injection of antigen-loaded dendritic cells in an autochthonous tumor model. J Immunol 2010; 184: 5954-5958
15. Dudley ME, Wunderlich JR, Yang JC, Sherry RM, Topalian SL, Restifo NP et al. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J Clin Oncol 2005; 23: 2346-2357 (Pubitemid 46218728)
16. Dudley ME, Yang JC, Sherry R, Hughes MS, Royal R, Kammula U et al. Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens. J Clin Oncol 2008; 26: 5233-5239
17. +T lymphocytes as a prognostic factor of survival in endometrial carcinoma. Clin Cancer Res 2004; 10: 4450-4456 (Pubitemid 38878888)
18. Thomas DL, Kim M, Bowerman NA, Narayanan S, Kranz DM, Schreiber H et al. Recurrence of intracranial tumors following adoptive T cell therapy can be prevented by direct and indirect killing aided by high levels of tumor antigen crosspresented on stromal cells. J Immunol 2009; 183: 1828-1837
19. +T cell tolerance to a tumor-associated antigen is maintained at the level of expansion rather than effector function. J Exp Med 2002; 195: 1407-1418 (Pubitemid 34602818)
20. Tanchot C, Lemonnier FA, Perarnau B, Freitas A-A, Rocha B. Differential requirements for survival and proliferation of CD8 naive or memory T cells. Science 1997; 276: 2057-2062 (Pubitemid 27443614)
21. +thymic emigrants. J Immunol 1998; 160: 3705-3712 (Pubitemid 28176071)
22. Murali-Krishna K, Lau LL, Sambhara S, Lemonnier F, Altman J, Ahmed R. Persistence of memory CD8 T cells in MHC class I-deficient mice. Science 1999; 286: 1377-1381
23. Schluns KS, Kieper WC, Jameson SC, Lefrancois L. Interleukin-7 mediates the homeostasis of naive andmemory CD8 T cells in vivo. Nat Immunol 2000; 1: 426-432
24. Tan JT, Dudl E, LeRoy E, Murray R, Sprent J, Weinberg KI et al. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc Natl Acad Sci USA 2001; 98: 8732-8737 (Pubitemid 32678096)
25. Lodolce JP, Boone DL, Chai S, Swain RE, Dassopoulos T, Trettin S et al. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 1998; 9: 669-676 (Pubitemid 28557595)
26. Kennedy MK, Glaccum M, Brown SN, Butz EA, Viney JL, Embers M et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med 2000; 191: 771-780.
27. +T cells in vivo by IL-15 Immunity 1998; 8: 591-599 (Pubitemid 28264750)
28. +memory T cells by opposing cytokines. Science 2000; 288: 675-678 (Pubitemid 30241571)
29. Virgin HW, Wherry EJ, Ahmed R. Redefining chronic viral infection. Cell 2009; 138: 30-50.
30. kBurn SD, Blattman JN, Wherry EJ. Viral antigen and extensive division maintain virus-specific CD8 T cells during chronic infection. J Exp Med 2007; 204: 941-949 (Pubitemid 46631621)
31. Fodor E, Devenish L, Engelhardt OG, Palese P, Brownlee GG, Garcia-Sastre A. Rescue of influenza A virus from recombinant DNA. J Virol 1999; 73: 9679-9682 (Pubitemid 29487131)
32. Stevenson PG, Efstathiou S, Doherty PC, Lehner PJ. Inhibition of MHC class Irestricted antigen presentation by gamma 2-herpesviruses. Proc Natl Acad Sci USA 2000; 97: 8455-8460. (Pubitemid 30639694)
33. Hurwitz A-A, Foster BA, Allison JP, Greenberg NM, Kwon ED. The TRAMP Mouse as a Model for Prostate Cancer. Current Protocols in Immunology. New YorkJohn Wiley & Sons, Inc.2001: 20.51-20.523
34. Shen CH, Talay O, Mahajan VS, Leskov IB, Eisen HN, Chen J. Antigen-bearing dendritic cells regulate the diverse pattern of memory CD8 T-cell development in different tissues. Proc Natl Acad Sci USA 2010; 107: 22587-22592
35. Wherry EJ, Ahmed R. Memory CD8 T-cell differentiation during viral infection. J Virol 2004; 78: 5535-5545 (Pubitemid 38661640)
36. Di Carlo E, D'Antuono T, Pompa P, Giuliani R, Rosini S, Stuppia L et al. The lack of epithelial interleukin-7 and BAFF/BLyS gene expression in prostate cancer as a possible mechanism of tumor escape from immunosurveillance. Clin Cancer Res 2009; 15: 2979-2987
37. Bromley SK, Thomas SY, Luster AD. Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics. Nat Immunol 2005; 6: 895-901 (Pubitemid 43090444)
38. Gallatin WM, Weissman IL, Butcher EC. A cell-surface molecule involved in organspecific homing of lymphocytes. 1983 J Immunol 2006; 177: 5-9
39. Becker TC, Wherry EJ, Boone D, Murali-Krishna K, Antia R, Ma A et al. Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J Exp Med 2002; 195: 1541-1548 (Pubitemid 34666068)
40. Schluns KS, Williams K, Ma A, Zheng XX, Lefrancois L. Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells. J Immunol 2002; 168: 4827-4831 (Pubitemid 34495942)
41. +T cells. J Exp Med 1997; 186: 239-245 (Pubitemid 27328024)
42. +T cells undergoing peripheral deletion in response to cross-presentation of self-antigen. J Exp Med 2001; 194: 707-717 (Pubitemid 32983008)
43. Wherry EJ, Blattman JN, Murali-Krishna K, van der Most R, Ahmed R. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol 2003; 77: 4911-4927 (Pubitemid 36402840)
44. Zajac AJ, Blattman JN, Murali-Krishna K, Sourdive DJ, Suresh M, Altman JD et al. Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med 1998; 188: 2205-2213 (Pubitemid 29028493)